YD Bio (YDES) Beginning Cash Balance (2024 - 2026)
YD Bio's (YDES) quarterly Beginning Cash Balance came in at $6.0 million in Q2 2026, up 91.8% year-over-year from $3.1 million in Q2 2025, and up 91.8% quarter-over-quarter from $3.1 million in Q4 2025.
Powered by 
Analysis
YD Bio (YDES) Beginning Cash Balance (2024 - 2026) Analysis & Trends
YD Bio (YDES) has reported Beginning Cash Balance for 3 consecutive years, with $6.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Beginning Cash Balance rose 91.8% year-over-year to $6.0 million in Q2 2026; TTM through Jun 2026 was $6.0 million, a 91.8% increase from a year earlier, with the FY2025 full-year figure at $3.1 million, up 3496.29% from the prior year.
- Beginning Cash Balance was $6.0 million for Q2 2026 at YD Bio, up from $3.1 million in the prior quarter.
- Over five years, Beginning Cash Balance peaked at $6.0 million in Q2 2026 and troughed at $87098.0 in Q4 2024.
- A 3-year average of $3.1 million and a median of $3.1 million in 2025 frame the typical range for Beginning Cash Balance.
- Across the five-year window, Beginning Cash Balance soared 3496.29% in 2025 and surged 91.8% in 2026, its largest moves.
- Over 3 years, Beginning Cash Balance stood at $87098.0 in 2024, then soared by 3496.29% to $3.1 million in 2025, then jumped by 91.8% to $6.0 million in 2026.
- The last three Beginning Cash Balance figures came in at $6.0 million (Q2 2026), $3.1 million (Q4 2025), and $3.1 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn |
| 10 | YD Bio | 225.82 Mn | 223.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.01 Mn |
| Dec 31, 2025 | 3.13 Mn |
| Jun 30, 2025 | 3.13 Mn |
| Dec 31, 2024 | 87,098.00 |
API Access
YD Bio Beginning Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=YDES&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "beginning-cash-balance", "ticker": "YDES", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=YDES&period=max&api_key=YOUR_API_KEY");
const data = await res.json();